The association of thrombin generation with bleeding outcomes in cardiac surgery: a prospective observational study

• Published in: Canadian journal of anesthesia 2022-03, Vol.69 (3), p.311-322
• Main Authors: Bartoszko, Justyna, Li, Han, Fitzgerald, John, Ho, Loretta T. S., Serrick, Cyril, Kahr, Walter H. A., Gross, Peter L., Karkouti, Keyvan
• Format: Article
• Language: English
• Subjects: Anesthesia; Anesthesiology; Blood Coagulation Tests; Cardiac Surgical Procedures - adverse effects; Cardiology; Cardiopulmonary Bypass - adverse effects; Critical Care Medicine; Female; Health care networks; Heart surgery; Hemostasis; Hospitals; Humans; Intensive; Laboratories; Medicine; Medicine & Public Health; Middle Aged; Observational studies; Pain management; Pain Medicine; Pediatrics; Pneumology/Respiratory System; Reports of Original Investigations; Thrombin
• ISSN: 0832-610X; 1496-8975
• DOI: 10.1007/s12630-021-02165-1

Background Cardiac surgery with cardiopulmonary bypass (CPB) is associated with coagulopathic bleeding. Impaired thrombin generation may be an important cause of coagulopathic bleeding but is poorly measured by existing hemostatic assays. We examined thrombin generation during cardiac surgery, using calibrated automated thrombography, and its association with bleeding outcomes. Methods We conducted a prospective observational study in 100 patients undergoing cardiac surgery with CPB. Calibrated automated thrombography parameters were expressed as a ratio of post-CPB values divided by pre-CPB values. The association of thrombin generation parameters for bleeding outcomes was compared with conventional tests of hemostasis, and the outcomes of patients with the most severe post-CPB impairment in thrombin generation (≥ 80% drop from baseline) were compared with the rest of the cohort. Results All 100 patients were included in the final analysis, with a mean age of 63 (12) yr, 31 (31%) female, and 94 (94%) undergoing bypass and/or valve surgery. Post-CPB, peak thrombin decreased by a median of 73% (interquartile range [IQR], 49–91%) ( P < 0.001) and total thrombin generation, expressed as the endogenous thrombin potential (ETP), decreased 56% [IQR, 30–83%] ( P < 0.001). In patients with ≥ 80% decrease in ETP, 21% required re-exploration for bleeding compared with 7% in the rest of the cohort ( P = 0.04), and 48% required medical or surgical treatment for hemostasis compared with 27% in the rest of the cohort ( P = 0.04). Conclusions Thrombin generation is significantly impaired by CPB and associated with higher bleeding severity. Clinical studies aimed at the identification and treatment of patients with impaired thrombin generation are warranted.